Labetuzumab, CAS 219649-07-7

Product Description: Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Stein R, et al. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy. Mol Cancer Ther. 2004 Dec;3(12):1559-64.

CAS Number: 219649-07-7

Molecular Weight: N/A

Compound Purity: 99.59

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• SKU: MEXHY-P99160-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99160-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK